Contineum Therapeutics (CTNM) EPS (Basic) (2023 - 2026)

Contineum Therapeutics (CTNM) recorded quarterly EPS (Basic) of -$0.39 in Q1 2026, up 20.41% quarter-over-quarter from -$0.49 in Q4 2025, and up 37.1% on a YoY basis from -$0.28 in Q1 2025.

Contineum Therapeutics (CTNM) EPS (Basic) (2023 - 2026) Analysis & Trends

Contineum Therapeutics' EPS (Basic) history runs 4 years deep, the most recent figure standing at -$0.39 for Q1 2026.

  • In Q1 2026, EPS (Basic) rose 37.1% year-over-year to -$0.39; the TTM figure through Mar 2026 stood at -$1.95 (up 1.52% YoY), while the FY2025 annual figure was -$2.17, changed 0.46% from the prior year.
  • EPS (Basic) was -$0.39 for Q1 2026 at Contineum Therapeutics, up from -$0.49 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $2.56 in Q2 2023 to a low of -$3.55 in Q1 2024.
  • Historically, EPS (Basic) has averaged -$0.79 across 4 years, with a median of -$0.53 in 2023.
  • Biggest YoY gain for EPS (Basic) was 85.13% in 2024; the steepest drop was 115.23% in 2024.
  • A 4-year view of EPS (Basic) shows it stood at -$0.53 in 2023, then fell by 7.55% to -$0.57 in 2024, then increased by 14.04% to -$0.49 in 2025, then increased by 20.41% to -$0.39 in 2026.
  • The last three EPS (Basic) figures came in at -$0.39 (Q1 2026), -$0.49 (Q4 2025), and -$0.45 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -0.68
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 3.06
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 0.00
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 0.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 0.00
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 0.00
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 4.06
9 Abivax 95.45 Bn 95.45 Bn - -0.06
10 Contineum Therapeutics 430.52 Mn 430.52 Mn - -0.39

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.39
Dec 31, 2025 -0.49
Sep 30, 2025 -0.45
Jun 30, 2025 -0.62
Mar 31, 2025 -0.62
Dec 31, 2024 -0.57
Sep 30, 2024 -0.40
Jun 30, 2024 -0.39
Mar 31, 2024 -3.55
Dec 31, 2023 -0.53
Sep 30, 2023 -2.69
Jun 30, 2023 2.56
Mar 31, 2023 -2.12